Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
NCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Led by Bristol-Myers Squibb · Updated on 2026-04-29

274

Participants Needed

74

Research Sites

72 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania with mixed features. The primary objective of the study is to evaluate the efficacy of KarXT compared to placebo in treating symptoms of mania during a 3-week inpatient period. The duration of the study including screening, the double-blind inpatient treatment period and safety-follow-up is no more than seven weeks.

CONDITIONS

Official Title

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have a primary diagnosis of Bipolar-I disorder established by a comprehensive psychiatric evaluation.
  • Participants must be experiencing an acute episode or relapse of mania or mania with mixed features (≤ 3 weeks).
  • Participants must require hospitalization for the acute exacerbation or relapse of mania.
  • Participants must have all psychotropic medications washed out in no more than 14 days prior to the first dose of the study drug.
  • Participants must have a Young Mania Rating Scale (YMRS) score of ≥ 20 at Screening and at Baseline.
  • Participants must have a Clinical Global Impressions-Bipolar (CGI-BP) ≥ 4 at Screening and at Baseline.
Not Eligible

You will not qualify if you...

  • Participants must not have any primary DSM-5-TR disorder, other than BP-I with mania or mania with mixed features within 12 months before screening, including BP-I with depression (for previous 3 months only), BP-II disorder, borderline personality disorder, major depressive disorder, and primary psychotic disorder, except mild anxiety disorders.
  • Participants must not have a primary diagnosis of BP-I with rapid cycling (≥ 4 distinct mood episodes in one year).
  • Participants must not have a DSM-5-TR diagnosis of moderate to severe substance use disorder (except tobacco use disorder) within the 12 months before screening, or current use as determined by urine toxicology or alcohol test.
  • Participants must not be at risk for suicidal behavior at screening or baseline as determined by clinical assessment and the Columbia-Suicide Severity Rating Scale (C-SSRS).
  • Participants must not have cirrhosis, liver cancer, or clinically significant liver disease based on liver function tests.
  • Other protocol-defined Inclusion/Exclusion criteria apply.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 74 locations

1

Pillar Clinical Research- Little Rock

Little Rock, Arkansas, United States, 72204

Actively Recruiting

2

Woodland Research Northwest

Rogers, Arkansas, United States, 72758

Actively Recruiting

3

Proscience Research Group

Culver City, California, United States, 90230

Actively Recruiting

4

Clinical Innovations, Inc. dba CITrials

Riverside, California, United States, 92506

Actively Recruiting

5

Collaborative Neuroscience Research, LLC

Torrance, California, United States, 90502

Actively Recruiting

6

Local Institution - 0036

Hialeah Gardens, Florida, United States, 33016

Withdrawn

7

Behavioral Clinical Research

Hollywood, Florida, United States, 33021

Actively Recruiting

8

LCC Medical Research Institute

Miami, Florida, United States, 33126

Actively Recruiting

9

Innovative Clinical Research, Inc.

Miami Lakes, Florida, United States, 33016

Actively Recruiting

10

South Florida Research Phase I-IV

Miami Springs, Florida, United States, 33166

Actively Recruiting

11

Local Institution - 0019

Tampa, Florida, United States, 33618

Withdrawn

12

Health Synergy Clinical Research

West Palm Beach, Florida, United States, 33407

Actively Recruiting

13

Atlanta Center for Medical Research

Atlanta, Georgia, United States, 30331

Actively Recruiting

14

CenExel iResearch, LLC

Decatur, Georgia, United States, 30030

Actively Recruiting

15

Local Institution - 0020

Chicago, Illinois, United States, 60640

Not Yet Recruiting

16

CBH Health

Gaithersburg, Maryland, United States, 20877

Actively Recruiting

17

Precise Research Centers

Flowood, Mississippi, United States, 39232

Actively Recruiting

18

Arch Clinical Trials

St Louis, Missouri, United States, 63141

Actively Recruiting

19

Local Institution - 0076

North Las Vegas, Nevada, United States, 89030

Withdrawn

20

Hassman Research Institute Marlton Site

Marlton, New Jersey, United States, 08053

Actively Recruiting

21

Local Institution - 0031

Marlton, New Jersey, United States, 08053

Withdrawn

22

Local Institution - 0075

Charlotte, North Carolina, United States, 28211

Withdrawn

23

University of Cincinnati Medical Center

Cincinnati, Ohio, United States, 45219

Actively Recruiting

24

Neuro-Behavioral Clinical Research

North Canton, Ohio, United States, 44720

Actively Recruiting

25

InSite Clinical Research

DeSoto, Texas, United States, 75115

Actively Recruiting

26

Local Institution - 0028

Houston, Texas, United States, 77021

Withdrawn

27

Pillar Clinical Research - Richardson

Richardson, Texas, United States, 75080

Actively Recruiting

28

Local Institution - 0009

Zagreb, City of Zagreb, Croatia, 10090

Withdrawn

29

Klinika za psihijatriju "Vrapče"

Zagreb, Croatia, 10090

Actively Recruiting

30

Klinika za psihijatriju "Vrapče"

Zagreb, Croatia, 10090

Actively Recruiting

31

Local Institution - 0078

Zagreb, Croatia, 10090

Not Yet Recruiting

32

Psihijatrijska bolnica "Sveti Ivan"

Zagreb, Croatia, 10090

Actively Recruiting

33

Local Institution - 0065

Vadodara, Gujarat, India, 390021

Not Yet Recruiting

34

Local Institution - 0082

Belagavi, Karnataka, India, 590010

Not Yet Recruiting

35

Local Institution - 0053

Kozhikode, Kerala, India, 673009

Not Yet Recruiting

36

Local Institution - 0051

Ludhiana, Punjab, India, 141001

Not Yet Recruiting

37

Local Institution - 0052

Hyderabad, Telangana, India, 500034

Not Yet Recruiting

38

Local Institution - 0055

Hyderabad, Telangana, India, 500082

Not Yet Recruiting

39

Local Institution - 0054

Kolkata, West Bengal, India, 700014

Not Yet Recruiting

40

Shalvata Mental Health Center

Hod HaSharon, Central District, Israel, 4534708

Actively Recruiting

41

Ness Ziona Mental Health Center

Ness Ziona, Central District, Israel, 7410001

Actively Recruiting

42

Local Institution - 0058

Petah Tikva, Central District, Israel, 4910002

Not Yet Recruiting

43

Sheba Medical Center

Ramat Gan, Central District, Israel, 5265601

Actively Recruiting

44

Be'er Sheva Mental Health Center

Beersheba, Southern District, Israel, 8461144

Actively Recruiting

45

Kfar Shaul Mental Health Center

Jerusalem, Israel, 9546105

Actively Recruiting

46

Local Institution - 0001

Milan, Lombardy, Italy, 20122

Withdrawn

47

Local Institution - 0056

Pisa, Tuscany, Italy, 56126

Withdrawn

48

Local Institution - 0007

Siena, Tuscany, Italy, 53100

Withdrawn

49

Local Institution - 0041

Ancona, Italy, 60126

Withdrawn

50

Local Institution - 0040

Genova, Italy, 16132

Withdrawn

51

Prof. Dr. Alexandru Obregia Psychiatry Hospital

Bucharest, Bucharest, Romania, 041914

Actively Recruiting

52

Prof. Dr. Alexandru Obregia Psychiatry Hospital

Bucharest, Bucharest, Romania, 041914

Actively Recruiting

53

Prof. Dr. Alexandru Obregia Psychiatry Hospital

Bucharest, Bucharest, Romania, 041914

Actively Recruiting

54

Prof. Dr. Alexandru Obregia Psychiatry Hospital

Bucharest, Bucharest, Romania, 041914

Actively Recruiting

55

Prof. Dr. Alexandru Obregia Psychiatry Hospital

Bucharest, Bucharest, Romania, 041914

Actively Recruiting

56

Prof. Dr. Alexandru Obregia Psychiatry Hospital

Bucharest, Bucharest, Romania, 041914

Actively Recruiting

57

Centrul de Evaluare și Tratament a Toxicodependenței pentru Tineri Sf.Stelian

Bucharest, Romania, 060222

Actively Recruiting

58

Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila

Bucharest, Romania, 0

Actively Recruiting

59

Local Institution - 0047

Iași, Romania, 700282

Not Yet Recruiting

60

Spitalul de Psihiatrie și Neurologie Brașov

Sanpetru /Brasov, Romania, 507190

Actively Recruiting

61

Local Institution - 0071

Košice, Košice Region, Slovakia, 040 01

Not Yet Recruiting

62

Local Institution - 0073

Košice, Košice Region, Slovakia, 040 01

Not Yet Recruiting

63

Local Institution - 0072

Vranov nad Topľou, Presov, Slovakia, 093 01

Not Yet Recruiting

64

Hospital Universitari Vall d'Hebron

Barcelona, Barcelona [Barcelona], Spain, 08035

Actively Recruiting

65

Osi Bilbao-Basurto

Bilbao, Basque Country, Spain, 48013

Actively Recruiting

66

Hospital Clínic de Barcelona

Barcelona, Catalunya [Cataluña], Spain, 08036

Actively Recruiting

67

Nacka Local Hospital

Nacka, Stockholms Län [se-01], Sweden, 131 45

Actively Recruiting

68

Local Institution - 0067

Uppsala, Uppsala Län [se-03], Sweden, 751 85

Withdrawn

69

Local Institution - 0070

Gothenburg, Västra Götalands Län [se-14], Sweden, 413 45

Withdrawn

70

Local Institution - 0088

Dnipro, Dnipropetrovsk Oblast, Ukraine, 49115

Not Yet Recruiting

71

Local Institution - 0092

Hlevakha, Kyiv Oblast, Ukraine, 08631

Not Yet Recruiting

72

Local Institution - 0093

Oleksandrivka, Odesa Oblast, Ukraine, 67513

Not Yet Recruiting

73

Local Institution - 0085

Vinnytsia, Vinnytsia Oblast, Ukraine, 21037

Not Yet Recruiting

74

Local Institution - 0094

Odesa, Ukraine, 65006

Not Yet Recruiting

Loading map...

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

F

First line of the email MUST contain NCT # and Site #.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) | DecenTrialz